Leerink Partnrs Predicts Lower Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Investment analysts at Leerink Partnrs lowered their Q3 2025 earnings estimates for Elevance Health in a research note issued on Thursday, January 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $9.36 for the quarter, down from their prior estimate of $9.66. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share. Leerink Partnrs also issued estimates for Elevance Health’s FY2025 earnings at $34.31 EPS and Q1 2026 earnings at $12.65 EPS.

A number of other equities research analysts have also issued reports on ELV. Raymond James set a $485.00 target price on Elevance Health in a research note on Friday, October 18th. Truist Financial dropped their price objective on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Barclays increased their target price on Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Mizuho cut their price target on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. Finally, Stephens lowered shares of Elevance Health from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $520.00 to $440.00 in a report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $524.47.

Elevance Health Price Performance

Elevance Health stock opened at $405.67 on Monday. Elevance Health has a 52 week low of $362.21 and a 52 week high of $567.26. The firm has a market capitalization of $94.08 billion, a PE ratio of 14.79, a P/E/G ratio of 1.11 and a beta of 0.84. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The firm’s 50-day simple moving average is $386.42 and its 200 day simple moving average is $460.49.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%.

Hedge Funds Weigh In On Elevance Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mackenzie Financial Corp raised its stake in shares of Elevance Health by 1.1% during the second quarter. Mackenzie Financial Corp now owns 73,964 shares of the company’s stock valued at $40,078,000 after purchasing an additional 773 shares in the last quarter. Kathmere Capital Management LLC acquired a new position in shares of Elevance Health during the second quarter valued at approximately $210,000. Ascent Group LLC lifted its position in Elevance Health by 30.2% in the second quarter. Ascent Group LLC now owns 4,903 shares of the company’s stock worth $2,657,000 after purchasing an additional 1,138 shares during the period. Creative Planning boosted its stake in Elevance Health by 10.3% during the 2nd quarter. Creative Planning now owns 31,156 shares of the company’s stock valued at $16,882,000 after purchasing an additional 2,901 shares in the last quarter. Finally, Magnolia Capital Advisors LLC bought a new position in Elevance Health during the second quarter valued at about $19,085,000. 89.24% of the stock is owned by institutional investors.

Elevance Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be paid a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a yield of 1.69%. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. Elevance Health’s payout ratio is presently 23.77%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.